title: Clinical outcome measures of psoriasis.
abstract: Several tools have been introduced in clinical trials to quantify the severity and the response to a given therapeutic regimen of both psoriasis and psoriatic arthritis. Each method present specific advantages and limitations. Here we will discuss some of the most popular clinical outcome measures of both psoriasis (Psoriasis Severity Index, Physician Global Assessment, National Psoriasis Fundation-Psoriasis Score, Dermatology Life Quality Index) and psoriatic arthritis (American College Rheumatology response criteria, Psoriatic Arthritis Response Criteria).
authors.affiliation: Department of Clinical Dermatology, San Gallicano Dermatological Institute, Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Bonifati
authors.forename: E
authors.initials: E
authors.lastname: Berardesca
mesh_terms: D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000592:standards; D006801:Humans; D007558:Italy; D017063:Outcome Assessment, Health Care / Q000592:standards; D010808:Physical Examination / Q000379:methods; D011379:Prognosis; D011565:Psoriasis / Q000175:diagnosis* / Q000188:drug therapy*; D011788:Quality of Life; D012107:Research Design; D012720:Severity of Illness Index; D012955:Societies, Medical; D016896:Treatment Outcome; D014481:United States